Substance use disorders have a profound impact on the course of severe mental illnesses and on the family, but little research has evaluated the impact of family intervention for this population. To address this question, a randomized controlled trial was conducted comparing a brief (2-3 mo) Family Education (ED) program with a longer-term (9-18 mo) program that combined education with teaching communication and problem-solving skills, Family Intervention for Dual Disorders (FIDD). A total of 108 clients (77% schizophrenia-spectrum) and a key relative were randomized to either ED or FIDD and assessed at baseline and every 6 months for 3 years. Rates of retention of families in both programs were moderate. Intent-to-treat analyses indicated that clients in both programs improved in psychiatric, substance abuse, and functional outcomes, as did key relatives in knowledge of co-occurring disorders, burden, and mental health functioning. Clients in FIDD had significantly less severe overall psychiatric symptoms and psychotic symptoms and tended to improve more in functioning. Relatives in FIDD improved more in mental health functioning and knowledge of co-occurring disorders. There were no consistent differences between the programs in substance abuse severity or family burden. The findings support the utility of family intervention for co-occurring disorders, and the added benefits of communication and problem-solving training, but also suggest the need to modify these programs to retain more families in treatment in order to provide them with the information and skills they need to overcome the effects of these disorders.
Introduction
Substance abuse in people with severe psychiatric disorders such as schizophrenia and bipolar disorder contributes to a worse course of illness, including more relapses and rehospitalizations, impaired social functioning, housing instability and homelessness, and medical and legal problems. 1, 2 Over the past 2 decades, a growing consensus has emerged that traditional parallel or sequential approaches to treating co-occurring psychiatric and substance use disorders with separate clinicians working for different treatment agencies are ineffective, 3, 4 leading to the development of integrated treatment models that target both disorders at the same time by the same clinicians. [5] [6] [7] [8] Research on integrated treatment has supported its effectiveness, 9, 10 although the data continue to be debated. 11 The preponderance of integrated treatment programs have focused on group interventions, [12] [13] [14] followed by individual models 15, 16 or their combination. 17, 18 Less attention has been paid to family interventions, 19 although there are several reasons why this modality may have special relevance to the treatment of co-occurring disorders.
Many people with co-occurring disorders live with or have regular contact with family members, who invest time and money to provide a combination of practical and emotional supports. 20, 21 Family involvement in the lives of people with co-occurring disorders is associated with an improved outcome of these disorders, 22, 23 suggesting that these supports are clinically beneficial. However, compared with severe mental illness alone, co-occurring disorders are associated with a range of negative effects on the family, including greater burden of care 24, 25 and family conflict. 24, [26] [27] [28] The result of the high stress of coping with a relative with a co-occurring disorder is often the loss of family support and ensuing negative outcomes
Participants
Inclusion criteria for the study were: (a) minimum 18 years old; (b) psychiatric diagnosis of schizophrenia, schizoaffective disorder, or bipolar disorder, based on the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) (SCID) 35 ; (c) diagnosis of active substance abuse or dependence within the past 6 months, based on the SCID; (d) at least 4 hours per week contact between the study client and index relative, close friend, or other person with a caring but nonprofessional relationship; (e) client currently receiving services at 1 of the 3 agencies participating in the study; and (f) willingness of the client and a family member to provide written informed consent for the study.
A total of 108 clients and key relatives consented to participate in the study and were randomized to 1 of the 2 family intervention programs. The flow of study recruitment, consent, engagement in the family programs, exposure to the family programs, and follow-up assessments is summarized in figure 1 . The characteristics of the clients and their key relatives randomized to the FIDD or ED programs are provided in table 1.
Measures
Assessments were conducted of clients and their key family member by trained interviewers who were blind to treatment assignment at baseline and every 6 months for 3 years postrandomization. Prior to assessing study participants, interviewers were trained on the instruments using live and taped interviews. Over the course of the study, a total of 4 interviewers assessed study participants in Boston and 3 interviewers in Los Angeles. Monthly calls were conducted with the interviewers to review ratings and discuss assessment questions. Audio recordings of interviews were randomly selected throughout the study and rated by an independent assessor to check on reliability (see below on ''Psychiatric symptoms'' section).
The client interviews evaluated substance use, psychiatric symptoms, overall functioning, medication adherence, knowledge of co-occurring disorders, social problemsolving skills, hospitalizations, days of homelessness, and incarcerations. Self-report information about hospitalizations and incarcerations was supplemented by routine medical record reviews. Rates of hospitalization, homelessness, and incarceration were relatively low over the 3-year study period, and thus for the purposes of statistical analyses, we computed the percentage of days of living in stable housing in the community for each 6-month assessment period. Clinician reports of client substance abuse were obtained from case managers or from the primary treating clinician. The interviews with the key relatives evaluated knowledge of co-occurring disorders, social problem-solving skills, mental and physical functioning, and family caregiving experience.
Substance Abuse. Days of excessive alcohol use and days of drug use over the past 6 months were assessed with the Timeline Follow-back Calendar, 36 adapted for people with severe mental illness, 8 and shown to be reliable in this population. 37 Ratings of alcohol and drug use
severity over the past 6 months were made by the case manager or another clinician using all available sources of clinic information (including interviews with staff members and medical record reviews) on the revised versions of the Alcohol Use Scale (AUS) and Drug Use Scale (DUS). 8 These measures, which are reliable and valid in persons with severe mental illness, 38 summarize the severity of substance abuse during the worst 1-month period over the past 6 months on a 5-point scale corresponding to DSM-IV criteria for substance use disorders: 1 = no use, 2 = use without impairment, 3 = abuse, 4 = dependence, and 5 = severe dependence resulting in hospitalizations or incarcerations.
Progressive movement toward treatment involvement, remission, and recovery from substance use disorders was evaluated by the case manager or another clinician with the revised Substance Abuse Treatment Scale (SATS). 8, 39 Low scores on this scale (1, 2) reflect initial engagement with a clinician, scores of 3 or 4 reflect regular contact with a clinician and initial reduction in substance use, scores of 5 or 6 reflect sustained reduction in substance use and initial remission of the substance use disorder, and scores or 7 or 8 reflect more sustained remission. The SATS has good reliability and validity in this population. 40 Psychiatric Symptoms, Medication Adherence, and Overall Functioning. Symptom severity was assessed with the expanded version of the Brief Psychiatric Rating Scale (BPRS), 41 a widely used measure including 24 items rated on 7-point anchored Likert scales. The 4-factor solution 
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Lost to all follow-up (n = 3) Could not be located (n = 2) Refused (n = 1)
Lost to all follow-up (n = 2) Could not be located (n = 1) Refused (n = 1)
Not eligible (n = 554) Client not interested (n = 74)
Relative not interested (n = 6) Client and relative not interested (n = 2) Family did not complete baseline assessment (n = 3)
Assessed for Eligibility (n = 749) for the BPRS 42 was used to compute factor scores for the statistical analyses: psychosis, depression, activation, and retardation. Based on a total of 47 randomly selected interviews rated by an independent assessor, intraclass correlation coefficients were computed and found to be high on the BPRS total score (0.86) and the subscales for psychosis (0.85), depression (0.97), and activation (0.85), indicating good interrater reliability. The interrater reliability for the retardation subscale could not be computed based on the audio recordings because this subscale relies heavily on the observation of nonverbal behavior.
The number of days over the past month the client reported not taking medication as prescribed was used to assess medication nonadherence. Overall psychiatric functioning was assessed with the Global Assessment Scale (GAS), 43 for which ratings range from 1 to 100, with low numbers corresponding to worse functioning.
Knowledge and Social Problem Solving. Client and key relative knowledge about the nature and treatment of co-occurring disorders were evaluated with 3 parallel versions of the knowledge test, depending on the client's primary psychiatric diagnosis (schizophrenia, schizoaffective disorder, or bipolar disorder). Each version contained 16 multiple choice questions pertaining to the symptoms and nature of the psychiatric disorder, the effects of substance use on the disorder, and treatment principles, with high numbers corresponding to greater knowledge. This test 45 This measure yields several problem-solving subscales (eg, cognitive, emotional, and behavioral styles) and provides an overall measure in which higher scores indicate a more planful step-by-step approach to solving problems (ie, define the problem, brainstorm solutions, etc.) consistent with problem-solving approach taught in the FIDD program.
Key Relative Mental and Physical Functioning. Functioning was assessed with the Medical Outcomes Study Short Form-12 (SF-12), which contains 12 self-report items pertaining to physical and mental health functioning. 46 Separate composite scores ranging between 0 (poor health) and 100 (excellent health) are computed corresponding to physical and mental health functioning. The SF-12 is a widely used measure of health functioning in the general population.
Family Caregiving. Selected subscales from the Family Experiences Interview Schedule (FEIS) 47 were employed to evaluate the effects on the relative of having a close relationship with someone with a mental illness. The FEIS is a semi-structured interview designed to capture both perceptions of burden and gratification related to this close relationship, with high scores corresponding to a worse family experience. We report here on the following FEIS subscales for which there were a sufficient number of completed answers that had an acceptable coefficient a (.6): benefits of the relationship, gratification, financial contributions to different areas of the client's life (both the scaled score and total dollars spent over past 30 d), and stigma about mental illness. In order to reduce skew in total dollars spent, this variable was log transformed for the statistical analyses.
Family Program Contacts and Participation in Family Support Groups. Following each contact with the family or individual relatives related to provision of FIDD or ED, the study therapist completed a contact sheet. These sheets indicated the purpose, time, location, and duration of the contact, as well as the focus and content of the session, including specific curriculum or skills that were taught. In addition, in order to evaluate participation in family support groups (eg, conducted by the National Alliance on Mental Illness) after completion of the family programs, at each 6-month assessment interview, the key relative was asked whether they had participated in any such groups over the previous 6 months.
Treatment Programs
The FIDD program and the ED program were standardized in a detailed manual and included educational handouts for the family members available in Mueser et al. 8 Both the ED and FIDD interventions were delivered by the same clinicians. We briefly describe each program here; for more details, see Mueser et al. 34 ED Program . ED was focused on teaching family members, including the client information about co-occurring disorders and their treatment in order to help them make informed treatment decisions and to access desired services within their mental health agency or their broader community. ED was provided in single-family sessions over 6-8 weekly 1-hour sessions, with all involved family members at a location convenient for the family (eg, home, clinic). Teaching was conducted using basic educational principles such as asking questions to elicit the family's expertise and experience, using didactic presentations and handouts to teach information and developing home assignments for family members to review educational materials. 32 Educational topics included: basic facts about the psychiatric disorder medications, the stress-vulnerability model of psychiatric disorders, the role of the family, facts about alcohol and drugs, motives and consequences of substance use, treatment of dual disorders, and infectious diseases. During family sessions, key relatives occasionally divulged information about their own substance use, or it was brought up by the client. The therapist encouraged self-disclosure about substance use on the part of relatives, without attempting to elicit it, and sought to help them to relate the educational materials to their own experiences, while maintaining the primary focus on the client's substance use problems.
FIDD Program. FIDD also taught the client and family members information about co-occurring disorders in order to facilitate their ability to make informed treatment decisions and access desired services, using the same curriculum and teaching techniques in single family sessions as ED. In addition, FIDD sought to reduce family tension and stress that could exacerbate psychiatric symptoms 48 and facilitate the ability of the family to address substance abuse problems by teaching communication and problemsolving skills using social learning methods such as role plays and home assignments to practice the skills. 31, 32 Motivation in family members to recognize the client's substance use as a problem and to work on addressing it was cultivated by adopting a stages of treatment approach, 8, 49 based on the stages of change model. 50 The stages of treatment concept informed the organization and pacing of family sessions by specifying appropriate therapeutic interventions consistent with family members' motivation to address substance use. Thus, the clinician initially focused on establishing a therapeutic relationship with the family (engagement stage), followed by providing information (and other strategies as necessary, such as motivational interviewing approaches incorporated into family problem solving) designed to motivate them to work on the client's substance abuse (persuasion stage), followed by attention to substance use reduction and abstinence when evidence of motivation to reduce was apparent (active treatment stage), and followed by helping the family develop relapse prevention strategies and attending more to other client needs when harmful use had ceased (relapse prevention stage). Family sessions were provided on a declining contact basis, starting with weekly sessions for approximately 3 months, followed by biweekly sessions for 6 months, and monthly sessions thereafter for a total duration of 9-18 months.
During FIDD sessions, key relatives sometimes talked about their own substance use or it was mentioned by the client. The therapist encouraged relatives who spontaneously discussed their substance use and its consequences, without pressuring them to disclose further. When the relative's use of substances appeared to contribute to the client's substance abuse or when the use appeared problematic in its own right, the therapist looked for opportunities to bring it into focus in a nonconfrontational manner, consistent with the stages of treatment and when possible to address it through family problem solving.
In the original FIDD program, families were also invited to participate in monthly multiple-family support groups that provided participants with information about co-occurring disorders and strategies for handing common challenges. 8, 33, 51 However, attendance rates at these sessions were low at both sites, typically below 50% of invited families. Because of low attendance, these groups were discontinued 3 years into the study. 34 Engagement and Exposure to the Family Programs. As described in our previous article, 34 engagement in either the FIDD or ED program was defined as completion of at least 2 protocol family sessions including the client and key relative. Extended exposure to the FIDD program was defined as completion of at least 3 problem-solving sessions, which typically follow sessions focusing on education and communication skills training. Exposure to ED was defined as completion of at least 6 sessions.
Usual Services. In addition to receiving either the FIDD or ED programs, all clients continued to participate in the usual array of clinical services they had been receiving prior to their involvement in the study. Across all 3 agencies, these services included pharmacological treatment, case management, day treatment, vocational rehabilitation, and referrals to substance abuse treatment. Family intervention was not provided on a systematic basis at any of the agencies, although multiple family education groups were offered (but rarely utilized by study participants) at the Los Angeles site.
Therapist Training, Supervision, and Fidelity Monitoring
The FIDD and ED programs were provided by the same clinicians, all of whom had advanced training in clinical psychology, and whose positions were funded by the research project. An initial training, including didactic presentations and role play practice, was provided to the family therapists, who each saw at least 3 practice cases before treating protocol families. Therapists were provided weekly in-person group supervision by master trainers over the course of the project. The therapists had regular contact with the treatment team and participated in treatment planning and review meetings.
Therapist fidelity to the FIDD and ED programs was monitored using the Clinician Adherence and Competency Scale, developed for this study. This scale provides 5-point ratings corresponding to the presence/absence, protocol adherence, and competence of 7 shared attributes of the FIDD and ED programs (agenda setting, review of clinical status, homework review, use of educational materials, rationale and teaching, homework assignment, and substance abuse focus) and 2 attributes unique to FIDD (communication skills training and problem solving). In addition, 8 global ratings were made for each session on 5-point scales ranging from 0 (unsatisfactory) to 4 (excellent). For this report, we focus on the global ratings for adherence to manual guidelines and overall clinician session quality. Ratings were provided by the 2 authors who developed the FIDD program. 33 
Procedure
Referrals for the study were made by clinicians at the sites, based on a brochure that described the project and visits to treatment teams by research staff. Once a referral was made, a research staff member met with the client, described the study, and if the client was interested, obtained informed consent. The client then identified a key relative, who was contacted to arrange a meeting, explain the study, and obtain informed consent. Other relatives were also invited to this meeting, although consent for the research study was obtained from only 1 key relative. When consents had been obtained, the baseline interview with the client was scheduled to confirm eligibility for the study. If the client completed the interview and was confirmed eligible, the baseline interview with the relative was scheduled. Clients and relatives were paid for completing assessment interviews but not for participating in the family programs.
Following completion of the relative's baseline interview, an offsite project coordinator was contacted, who randomized the family to either the FIDD or ED program using a computer program. No one was aware of the randomization sequence in advance. Separate randomization sequences were used for each of the 3 agencies where the study took place, stratified by diagnosis (schizophrenia or schizoaffective vs bipolar), and whether or not the client was living with the key relative.
Power Analysis
To determine the desired sample size, we focused on detecting significant differences between FIDD and ED in alcohol and drug abuse outcomes (as measured on the AUS, DUS, and SATS), based on Stanton and Shadish's 52 meta-analysis of family-couple intervention for substance use disorders, which found average effect sizes in the 0.4 d 0.6 range. As methods for evaluating power in mixed model linear regression approaches had not been established at this time, we estimated power based on analysis of covariance with endpoint scores as the dependent variable and baseline as the covariate, using SamplePower. 53 We planned on enrolling 70 families in each treatment group and assumed an attrition rate of 10% per year for 2 years, resulting in a final group size of 56 families in each program. We set a at .05 and estimated power to be 0.85 for a 2-tailed test to detect to detect an effect size of d = 0.5. We believed that this was a conservative estimate of power, given that longitudinal analyses based on mixed effects linear models would be able to more precisely evaluate treatment effects while also accommodating missing data. When we had difficulty recruiting the projected sample size of 140 participants, we increased the follow-up period from 2 to 3 years for the 108 families recruited.
Statistical Analysis
In a previous article, we compared the 2 study sites (Boston and Los Angeles) and treatment programs (ED and FIDD) on demographic and clinical characteristics at baseline, as well as the rates of engagement in and long-term exposure to each program, using v 2 analyses for categorical variables and t tests for continuous variables. 34 We also explored predictors of engagement and exposure to the family programs using these same tests and multiple logistic regressions. We briefly summarize these findings in the ''Results'' section.
For the current report, because of the significant rate of attrition from research during the third year of the study, we first explored whether there were differences in treatment group assignment, demographics, or baseline characteristics between the clients or key relatives who participated in the final 36-month assessment and those who did not by performing v 2 analyses and t tests. We then computed descriptive statistics (means, SDs) for the fidelity assessments of therapists' adherence to the FIDD and ED programs and their overall competence. Next, we compared the proportion of relatives who reported participating in nonstudy related family support groups following completion of their assigned program (study months 6-36 for ED and study months 18-36 for FIDD). Because the rates of participation in these groups were low, we conducted a v 2 analysis to compare the FIDD and ED groups in whether the key relatives had attended any such groups during the follow-up period.
To evaluate trend changes in the primary outcomes from baseline over the entire study period, mixed-effects linear regression models for both treatment groups combined were fitted using SAS PROC MIXED. 54 Intent-totreat analyses were conducted to compare the FIDD and ED groups on the primary outcomes using mixed effects linear regression ANCOVA models, 55, 56 which can accommodate correlated data by selecting appropriate covariance structures as well as missing data with maximum likelihood estimation, 57 using the SAS PROC MIXED procedure. For these analyses, we obtained estimates of SE in PROC MIXED by using the ''empirical'' estimate option, based on ''sandwich estimation. '' 58 After exploring interactions between group and potential independent variables (including gender, site, ethnicity, psychiatric diagnosis, whether the client was living with the key relative, and conjugal vs nonconjugal relationship between client and key relative), gender, and site were selected to include in the analyses. The baseline variable and educational level were included in these analyses as covariates, and group (FIDD vs ED), site (Boston vs Los Angeles), gender, and all 2-way interactions were the independent variables, as well as time. The main effect for group is a test of whether clients or relatives differed across all of the follow-up assessments, after controlling for baseline. Due to numerous 0's for the FEIS Stigma subscale, time and group analyses for this variable were evaluated using generalized estimating equations analysis. 59 Finally, to explore the effects of engagement in FIDD and ED programs, we repeated the same mixed effects linear regression models on client and key relative outcomes for families who were successfully engaged in their assigned treatment program. A very similar pattern of results was found to that of the intent-to-treat analyses. Thus, these findings are not presented here.
Results
Summary of Findings From Previous Report
Comparisons of the study sites indicated that clients in Los Angeles were more likely to be Latino and to be living with the key relative than those in Boston. 34 Clients in Los Angeles also had more severe overall symptoms on the BPRS and BPRS depression, activation, and psychosis subscales were more likely to have a drug use disorder or amphetamine use disorder and had more severe drug abuse on the DUS. Clients in Boston were more likely to have a cocaine or opiate use disorder. The key relatives in Boston reported perceiving less benefit in their relationship with the client and more burden and were more likely to have drunk to intoxication or to have used drugs over the past 30 days than those in Los Angeles, although overall the rate of substance use in the relatives over the past month was low at both sites (21%).
There were no significant client or key relative differences at baseline between families randomized to FIDD or ED. Forty-six of 52 families (88%) were engaged in the FIDD program and received an average of 19.59 sessions (SD = 11.38), compared with 47/56 of families (84%) in ED who received an average of 6.66 sessions (SD = 1.72). Among the 52 families in FIDD, 32 (66%) had extended exposure to the program (or 70% of the 46 families engaged in FIDD), compared with 31/56 (55%) families in ED (or 66% of the 47 families engaged in ED).
There were 3 consistent predictors of engagement and exposure to the FIDD and ED programs: site (Boston higher than Los Angeles), absence of client amphetamine use disorder, and key relative working full time (rather than part-time or not working). Although the univariate analyses identified several other variables were related to engagement or exposure, the multiple logistic regressions indicated only 1 unique predictor of engagement and 2 unique predictors of exposure. Families in which the key relative perceived less benefit in their relationship with the client were more likely to be engaged in treatment. Families of clients who were male and had fewer days of drug use over the past 6 months were more likely to be exposed to their assigned program. Family member substance abuse was not related to either engagement or exposure.
Results for Current Report
Comparisons of the 48 clients who completed the 3-year assessment with the 50 who did not indicated 3 significant differences at baseline. Clients who completed the final assessment were less likely at baseline to have an opiate use disorder than those who did not (21% vs 49%, respectively), v 2 = 3.84, df = 1, P = .05, had less severe drug abuse ratings on the DUS (Ms = 3.17 vs 3.76), t = 2.94, df = 104, P = .04, and used drugs on fewer days over the previous 6 months (Ms = 26.63 vs 54.32), t = 2.93, df = 106, P = .004.
Fidelity assessments of clinician adherence to FIDD, based on 392 sessions, indicated an overall adherence rating of 3.28 (SD = 1.10) and overall session quality rating of 3.37 (SD = 0.95), falling between the anchors of very good (3) and excellent (4) . Fidelity ratings for ED, based on 102 sessions, indicated an overall adherence rating of 3.52 (SD = 0.89) and overall session quality rating of 3.60 (SD = 0.71). Thus, both the FIDD and ED programs were implemented in accordance with the manual and with very good clinical skill.
Among key relatives assigned to FIDD, 6 of 40 (15%) attended a family support group between completing the program and the end of the study (18-36 mo) . Among the relatives assigned to ED, 5 of 46 (11%) attended a family support group between completing the program and the end of the study (6-36 mo). This difference was not significant, v 2 = 0.33, df = 1, NS. Descriptive statistics for the client outcomes in the FIDD and ED programs across the study assessments and the combined time effects for both groups are summarized in table 2. Most outcomes improved significantly over the study period, including involvement in substance abuse treatment on the SATS, alcohol use and drug use severity on the AUS and DUS for clients with an alcohol use and drug use disorder at baseline, respectively, overall symptom severity on the BPRS and the BPRS depression and retardation subscales, stable days in the community, overall functioning on the GAS, and knowledge about co-occurring disorders. Marginally significant improvements were also present for the number of days using drugs, number of days not taking prescribed medications, and the BPRS activation and psychosis subscales.
The mixed effects linear regression ANCOVA models indicated several significant differences in client outcomes between the ED and FIDD groups over the follow-up assessments as well as interactions between treatment group and gender or site. Significant group effects favoring FIDD over ED were present for BPRS total score, F = 3.79, df = 1,86, P = .05, and the psychosis subscale, F = 7.10, df = 1,86, P = .009. The effect size, based on comparing the baseline level with the average follow-up level for the FIDD and ED groups, was 0.17 for BPRS total score and 0.32 for the psychosis subscale. There was also a marginally significant effect favoring FIDD over ED for overall client functioning on the GAS, F = 2.95, df = 1,86, P = .08.
The analyses also indicated several significant interactions between treatment group and gender. Significant interactions were found for days of drinking, F = 5.05, df = 1,60, P = .03 and BPRS psychosis, F = 6.13, df = 1,86, P = .01. After controlling for baseline alcohol use, men in FIDD had fewer days of drinking over the course of the study (adjusted M = 19.78) than in ED (adjusted M = 34.70), whereas there was a weaker trend in the opposite direction with women in FIDD having somewhat more days of alcohol use (adjusted M = 34.05) than women in ED (adjusted M = 24.10). For BPRS Psychosis, FIDD had a major impact on reducing psychotic symptoms in women (adjusted M = 1.71) compared with ED (adjusted M = 2.45), whereas for men the impact of FIDD on psychosis was similar (adjusted M = 1.87) to the effect of ED (adjusted M = 1.71).
There were also significant interactions between treatment group and site for BPRS retardation, F = 6.87, df = 1,86, P = .01, days of not taking prescribed medication, F = 4.62, df = 1,78, P = .04, and the Social K. T. Mueser et al. Problem-Solving Scale, F = 6.10, df = 1,76, P = .01. Clients assigned to FIDD in Boston had lower BPRS retardation scores than those in ED (adjusted Ms = 1.59, 1.90, respectively), whereas in Los Angeles, the retardation scores for clients in the 2 programs were similar (adjusted Ms = 1.68 and 1.58, respectively). In Los Angeles, clients in FIDD had fewer days of medication nonadherence than clients in ED (adjusted Ms = 1.93, 4.26, respectively), whereas in Boston, there was a weaker trend in the opposite direction (adjusted Ms = 4.01, 2.87, respectively). Clients in FIDD in Boston had higher self-rated Social Problem-Solving Skills than those in ED (adjusted Ms = 143.23, 129.70, respectively), whereas in Los Angeles, the difference between the groups was less pronounced (adjusted Ms = 142.75, 132.73, respectively). Similar descriptive statistics and overall time effects for the relative outcomes are displayed in table 3. Significant improvements were observed for relative knowledge about co-occurring disorders, the mental component on the SF-12, and financial expenditures (both scaled score and dollars spent in the past 30 d), worry, and stigma on the FEIS.
The analyses of relative outcomes indicated significant treatment group differences in knowledge of co-occurring disorders, F = 11.55, df = 1,75, P = .001, and the mental component of the SF-12, F = 4.48, df = 1,78, P = .04, and a significant group by site interaction for the mental component of the SF-12, F = 4.37, df = 1,78, P = .04. Relatives who in FIDD had greater increases in knowledge of co-occurring disorders, F = 11.55, df = 1,75, P = .001, and more improvement in the mental component of the SF-12, F = 4.48, df = 1,78, P = .04, compared with relatives in ED. The interaction between treatment group and site showed that relatives in Los Angeles who participated in FIDD improved more on the mental component of the SF-12 than ED (adjusted Ms = 51.93, 46.12, respectively), whereas this effect was less pronounced in Boston (adjusted Ms = 47.34, 46.85, respectively).
Discussion
Clients in both the FIDD and the brief ED programs showed significant improvements across a range of outcomes over the 3-year study. Clients in both programs improved in substance abuse, overall psychiatric symptoms, stable days in the community, and global functioning. This pattern and degree of improvement is comparable to other long-term outcome studies evaluating different case managementapproachesto thedelivery of integratedtreatment for co-occurring disorders in similar clients, 18, 60 although the effects of the natural course of the disorders and ''regression to the mean'' cannot be discounted.
The key relatives of clients in both the FIDD and ED programs also demonstrated significant improvements in several outcome areas over the treatment and follow-up period. Specifically, relatives improved in their mental functioning as well as their financial involvement in different areas of the client's life, worry, and stigmatizing beliefs about mental illness, although there were no changes in family member perceptions of the benefits or gratitude regarding their relationship with their client relative. These improvements in family burden and distress are consistent with the results of other family interventions for severe mental illness, [61] [62] [63] [64] although previous studies have not evaluated the impact of family treatment for people with co-occurring disorders. The findings also suggest that an increased focus on improving family resiliency in coping with co-occurring disorders could result in a stronger impact on family members 65 . Clients randomized to the FIDD program had less severe general psychiatric symptoms (specifically psychotic symptoms) and showed a marginally significant trend toward better overall functioning than those in ED. Haddock and colleagues 66 also found that family intervention combined with individual client motivational interviewing and cognitive-behavioral therapy improved the functioning of clients with co-occurring disorders more than usual care. The present study is the first to report these effects for family intervention alone in clients with co-occurring disorders, although the findings are in line with other research showing that long-term family interventions are more effective than short-term programs at preventing relapses and improving functioning in people with severe mental illness. [67] [68] [69] The magnitude of the effect size for more improvement in overall symptoms for FIDD was in the small range (0.17), suggesting it was not clinically significant, whereas the effect size for lower psychosis scores was in the small to moderate range (0.34), suggestive of more clinically significant change, in at least some clients. The trend toward improved functioning for clients in FIDD in this study is similar to controlled research on integrated treatment for co-occurring disorders, especially group interventions, although less consistent findings have been reported for reduced symptom severity. 9 The FIDD program also produced stronger benefits in terms of the key relative's mental health functioning than the ED program, suggesting that reduced client psychiatric symptoms may be an important contributor to mental health well-being in relatives coping with a family member with a co-occurring disorder.
An unexpected finding was that the key relatives who participated in FIDD improved more in their knowledge of co-occurring disorders than those who received ED. This greater knowledge acquisition occurred despite the fact that the educational curriculum taught in the 2 programs was identical, and families in both programs received a similar number of sessions devoted to education. It is possible that the long-term nature of FIDD provided more opportunities for family members to process and assimilate the educational content than ED. In addition, as problems and challenges arose in the client's life K. T. Mueser et al. 65) throughout treatment (eg, stressors, difficulties in functioning, medical issues), the family member may have been able to see firsthand how the client's symptoms and diagnoses were affected by these experiences.
Contrary to our hypothesis, FIDD was not more effective than ED at improving substance abuse, although both groups improved significantly on the primary substance use disorder outcomes, including alcohol use disorder (AUS), drug use disorder (DUS), and engagement and progress in substance abuse treatment (SATS). In addition, the results did not confirm the hypothesized greater gains in social problem-solving skills for participants in FIDD program than ED, despite FIDD's intended focus on teaching communication and problem-solving skills. These 2 findings may be related because improved problem-solving skills were expected to contribute to better substance abuse outcomes for clients in the FIDD program. One factor that may have contributed to the lack of differences in these outcomes was the less than optimal level of exposure to the problem-solving training component of FIDD-only 66% of the families stayed in treatment long enough to have substantial exposure to this skill. Furthermore, greater severity of drug abuse at baseline predicted lower levels of long-term exposure to the FIDD, defined as completion of at least 3 problem-solving sessions. 34 Thus, those families who may have stood to benefit the most from the problemsolving training in FIDD were less likely to receive it. These findings suggest that families who have a relative with a co-occurring disorder may benefit from an increased focus early in treatment on exploring and enhancing motivation to work on substance use problems as a family, as well as practical strategies for more immediately reducing the disruptive effects of substance use on the family.
Two interactions between treatment group and gender were significant. Men who were assigned to the FIDD program showed significantly greater reductions in days of alcohol use than those in ED, while there was no difference between the alcohol use of women in the 2 programs. In contrast, while participants in FIDD had less severe psychotic symptoms than those in ED, this effect was more prominent in women. The contradictory nature of these 2 interactions, with men in FIDD benefiting more in one outcome (alcohol use) and women in another outcome (psychotic symptoms), the absence of a pattern of similar interactions in the related domains of substance abuse and psychiatric symptoms, and the number of statistical tests performed suggests that these findings may be spurious.
Inconsistent interactions were also found between treatment program and site. Clients in Boston who participated in FIDD showed greater improvement in social problem-solving skills and the BPRS retardation subscale than those in ED, whereas these differences were not observed in Los Angeles. In contrast, while the relatives in FIDD tended to report more improvements in their mental health functioning than those in ED, this effect was more prominent in Los Angeles than Boston. As with the gender differences, the contradictory nature of these 3 interactions, with the FIDD program achieving superior outcomes at the Boston site in some areas (client social problem solving, BPRS retardation) and FIDD improving more at the Los Angeles site in other areas (relative mental health functioning), are difficult to interpret in the absence of similar interactions in the related domains of relative social problem-solving, psychiatric symptoms, and relative outcomes.
Despite research showing moderate levels of family contact for clients with co-occurring disorders, 22 there were significant challenges recruiting families and retaining them in treatment, as previously reported in another study that combined family intervention with individual client treatment for dual disorders. 19 These difficulties suggest that the present findings may have limited generalizability to the broader population of people with cooccurring disorders, especially those with more severe drug use problems who were less likely to have longterm exposure to the family programs and more likely to be missing from the final 36-month assessment. 34 The problems with recruitment and retention in treatment also raise important feasibility questions about family treatment of this population. Further work is need to develop family programs for this population that are more successful at engaging and retaining families in treatment and providing them with the information and skills needed to overcome the effects of co-occurring disorders in a family member. Focus groups with families and clinicians aimed at evaluating what families need, similar to groups conducted during the initial development of the FIDD program, 33 could be one valuable strategy for partnering with families to improve the program.
Several methodological limitations of this study should be noted. The total sample size of 108 was lower than the initially planned size of 140, and therefore, there was limited statistical power to detect main differences between the FIDD and ED programs, as well as potential interactions between treatment group and variables such as gender, site, and ethnicity. While the follow-up period was extended from 2 to 3 years in an attempt to partly compensate for reduced power from the lower sample size, a significant proportion of families could not be contacted for the 30-and 36-month assessments, possibly in part due to the need to obtain consent from many families to extend their participation in the study. The combination of the smaller than anticipated sample size, and the significant rate of attrition from research, especially during the last year of the study, undoubtedly reduced power to detect significant differences between the FIDD and ED treatment groups. Although power calculations are valuable in planning research, there is also a consensus that the computation of postexperimental power is inappropriate because it does not provide additional useful information beyond the results of the statistical tests. [70] [71] [72] Another limitation of the study design was that the differences between the core components of the FIDD and ED programs were confounded by the different duration of each program. That is, the brief ED program was based on an educational approach to family treatment of co-occurring disorders, whereas the longer-term FIDD program employed a combination of education, communication skills training, and teaching problemsolving skills. Thus, the better outcomes associated with FIDD cannot be attributed to the skills training component of the program because the longer treatment duration of FIDD (or a combination of the 2) could be the critical ingredient. Research comparing longer term family educational programs 73 with multicomponent programs of similar length is needed to disentangle the added contribution of components such as skills training to improved outcomes. A related limitation was the lack of a treatment-as-usual group, making it impossible to determine how much of the improvement in client and relatives outcomes was due to the shared elements of the 2 family intervention programs, and how much could be attributed to other treatments that clients were receiving or the natural course of co-occurring disorders.
In summary, clients with co-occurring severe mental illness and substance use disorders and their key relatives who were assigned to either a brief (2-3 mo) education program (ED) or a longer term (9-18 mo) program including education and training in communication and problem-solving skills (FIDD) showed improvements in a range of outcomes related to psychiatric illness severity, substance abuse, psychosocial functioning, and family functioning over the 3-year study period. The longer term skills-oriented FIDD program was associated with greater improvements in client psychiatric symptoms and functioning, and relatives' knowledge of co-occurring disorders and mental health functioning, but not substance abuse. However, recruitment and retention of families in the 2 programs were problematic, suggesting the need for even briefer, more targeted intervention aimed at engaging and motivating families to participate in treatment. Focusing early contacts with family members on building rapport and preparing them for treatment may lay the necessary groundwork for intermediate and longer term family intervention such as the ED and FIDD programs.
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